These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12727082)

  • 1. Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection.
    Hiramatsu K; Murakami J; Kishi K; Hirata N; Yamasaki T; Kadota J; Shibata T; Nasu M
    Int J Antimicrob Agents; 2003 May; 21(5):471-7. PubMed ID: 12727082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.
    Murakami J; Kishi K; Hirai K; Hiramatsu K; Yamasaki T; Nasu M
    Int J Antimicrob Agents; 2000 Jul; 15(2):103-9. PubMed ID: 10854805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibiotics, levofloxacin and fosfomycin, on a mouse model with Escherichia coli O157 infection.
    Isogai E; Isogai H; Hayashi S; Kubota T; Kimura K; Fujii N; Ohtani T; Sato K
    Microbiol Immunol; 2000; 44(2):89-95. PubMed ID: 10803495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6.
    Taguchi H; Takahashi M; Yamaguchi H; Osaki T; Komatsu A; Fujioka Y; Kamiya S
    J Med Microbiol; 2002 Apr; 51(4):336-343. PubMed ID: 11926740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
    Isogai E; Isogai H; Kimura K; Hayashi S; Kubota T; Fujii N; Takeshi K
    Infect Immun; 1998 Jan; 66(1):197-202. PubMed ID: 9423858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of anti-TNF-alpha antibody and levofloxacin (LVFX) in a mouse model of enterohemorrhagic Escherichia coli O157 infection.
    Isogai E; Isogai H; Hirose K; Kubota T; Kimura K; Fujii N; Hayashi S; Takeshi K; Oguma K
    Comp Immunol Microbiol Infect Dis; 2001 Oct; 24(4):217-31. PubMed ID: 11561957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection.
    Isogai E; Isogai H; Hirose K; Hayashi S; Oguma K
    Curr Microbiol; 2001 Apr; 42(4):248-51. PubMed ID: 11178724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
    Flores-Villaseñor H; Canizalez-Román A; Velazquez-Roman J; Nazmi K; Bolscher JG; Leon-Sicairos N
    Biochem Cell Biol; 2012 Jun; 90(3):405-11. PubMed ID: 22332993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of enterohemorrhagic Escherichia coli O157:H7 by using a multiplex real-time PCR assay for genes encoding intimin and Shiga toxins.
    Sharma VK; Dean-Nystrom EA
    Vet Microbiol; 2003 May; 93(3):247-60. PubMed ID: 12695048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagitannin from Quercus infectoria eradicates intestinal colonization and prevents renal injuries in mice infected with Escherichia coli O157 : H7.
    Voravuthikunchai SP; Suwalak S; Mitranan W
    J Med Microbiol; 2012 Oct; 61(Pt 10):1366-1372. PubMed ID: 22790205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice].
    Sawamura S; Tanaka K; Koga Y
    Kansenshogaku Zasshi; 1999 Oct; 73(10):1054-63. PubMed ID: 10565122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice.
    Funatogawa K; Ide T; Kirikae F; Saruta K; Nakano M; Kirikae T
    Microbiol Immunol; 2002; 46(11):761-6. PubMed ID: 12516772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain.
    Isogai E; Isogai H; Takeshi K; Nishikawa T
    Microbiol Immunol; 1998; 42(2):125-8. PubMed ID: 9572044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
    Kurioka T; Yunou Y; Harada H; Kita E
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
    Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM
    Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
    Yoshimura K; Fujii J; Taniguchi H; Yoshida S
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):101-8. PubMed ID: 10536295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-automated fluorogenic PCR assays (TaqMan) forrapid detection of Escherichia coli O157:H7 and other shiga toxigenic E. coli.
    Sharma VK; Dean-Nystrom EA; Casey TA
    Mol Cell Probes; 1999 Aug; 13(4):291-302. PubMed ID: 10441202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.